Protein tyrosine kinase inhibitors inhibit both proliferation and chemotaxis of vascular smooth muscle cells.
Shimokado
K
K
National Cardiovascular Center Research Institute, Osaka, Japan.
Yokota
T
T
Kosaka
C
C
Zen
K
K
Sasaguri
T
T
Masuda
J
J
Ogata
J
J
D000818:Animals; D001161:Arteriosclerosis / Q000201:enzymology / Q000473:pathology; D002396:Catechols / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects*; D002633:Chemotaxis / Q000187:drug effects*; D003599:Cytoskeleton / Q000187:drug effects / Q000648:ultrastructure; D009131:Muscle, Smooth, Vascular / Q000166:cytology*; D009570:Nitriles / Q000494:pharmacology*; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*; D020032:Tyrphostins
D002396:Catechols; D009570:Nitriles; D010982:Platelet-Derived Growth Factor; D020032:Tyrphostins; C060152:tyrphostin 47; D011505:Protein-Tyrosine Kinases